These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 14964108

  • 1. [Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease].
    Vestbo J.
    Ugeskr Laeger; 2004 Jan 19; 166(4):271-4. PubMed ID: 14964108
    [No Abstract] [Full Text] [Related]

  • 2. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial.
    Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, Anderson J, Maden C, TRial of Inhaled STeroids ANd long-acting beta2 agonists study group.
    Lancet; 2003 Feb 08; 361(9356):449-56. PubMed ID: 12583942
    [Abstract] [Full Text] [Related]

  • 3. [Inhalation of beta-2 agonists or corticosteroids as single drugs in comparison with combination therapy of patients with COPD].
    Steurer-Stey C.
    Praxis (Bern 1994); 2003 Jul 30; 92(31-32):1324-5. PubMed ID: 12934343
    [No Abstract] [Full Text] [Related]

  • 4. [Salmeterol + fluticasone in COPD. Complementary treatment principles hold true in the COPD management, too].
    MMW Fortschr Med; 2003 Nov 13; 145(46):47. PubMed ID: 14699834
    [No Abstract] [Full Text] [Related]

  • 5. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease.
    Mahler DA, Wire P, Horstman D, Chang CN, Yates J, Fischer T, Shah T.
    Am J Respir Crit Care Med; 2002 Oct 15; 166(8):1084-91. PubMed ID: 12379552
    [Abstract] [Full Text] [Related]

  • 6. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease.
    Barnes NC, Qiu YS, Pavord ID, Parker D, Davis PA, Zhu J, Johnson M, Thomson NC, Jeffery PK, SCO30005 Study Group.
    Am J Respir Crit Care Med; 2006 Apr 01; 173(7):736-43. PubMed ID: 16424444
    [Abstract] [Full Text] [Related]

  • 7. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
    Vestbo J, Pauwels R, Anderson JA, Jones P, Calverley P, TRISTSAN study group.
    Thorax; 2005 Apr 01; 60(4):301-4. PubMed ID: 15790985
    [Abstract] [Full Text] [Related]

  • 8. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
    MMW Fortschr Med; 2002 Oct 31; 144(44):55. PubMed ID: 12494604
    [No Abstract] [Full Text] [Related]

  • 9. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R, Make B.
    COPD; 2008 Aug 31; 5(4):221-7. PubMed ID: 18671147
    [Abstract] [Full Text] [Related]

  • 10. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
    Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC, COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group.
    Thorax; 2005 Jun 31; 60(6):480-7. PubMed ID: 15923248
    [Abstract] [Full Text] [Related]

  • 11. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease.
    Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, York E, Mainra RR, Ramesh W, Melenka LS, Wilde E, Cowie RL, Williams D, Gan WQ, Rousseau R, ABC (Advair, Biomarkers in COPD) Investigators.
    Am J Respir Crit Care Med; 2008 Jun 01; 177(11):1207-14. PubMed ID: 18310480
    [Abstract] [Full Text] [Related]

  • 12. The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.
    Make B, Hanania NA, ZuWallack R, Kalberg C, Emmett A, Brown CP, Knobil K.
    Clin Ther; 2005 May 01; 27(5):531-42. PubMed ID: 15978302
    [Abstract] [Full Text] [Related]

  • 13. COPD: treatments benefit patients.
    Rennard SI.
    Lancet; 2003 Feb 08; 361(9356):444-5. PubMed ID: 12583937
    [No Abstract] [Full Text] [Related]

  • 14. Fluticasone/salmeterol: labeling change.
    Prescrire Int; 2008 Dec 08; 17(98):229. PubMed ID: 19418648
    [Abstract] [Full Text] [Related]

  • 15. Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction.
    Lindberg A, Szalai Z, Pullerits T, Radeczky E.
    Respirology; 2007 Sep 08; 12(5):732-9. PubMed ID: 17875063
    [Abstract] [Full Text] [Related]

  • 16. [New studies refute steroid opponents. COPD--after all a case for corticosteroids?].
    Calverley P.
    MMW Fortschr Med; 2003 Jun 12; 145(24):20. PubMed ID: 12866294
    [No Abstract] [Full Text] [Related]

  • 17. Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.
    Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C.
    Respir Med; 2008 Aug 12; 102(8):1099-108. PubMed ID: 18614347
    [Abstract] [Full Text] [Related]

  • 18. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
    Kobayashi Y, Yasuba H, Kudou M, Kita H.
    J Asthma; 2007 Mar 12; 44(2):77-81. PubMed ID: 17454319
    [Abstract] [Full Text] [Related]

  • 19. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
    COPD; 2007 Jun 12; 4(2):127-34. PubMed ID: 17530506
    [Abstract] [Full Text] [Related]

  • 20. Combined salmeterol and fluticasone for COPD.
    Vassiliou V.
    Lancet; 2003 May 10; 361(9369):1651; author reply 1652-3. PubMed ID: 12747901
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.